4//SEC Filing
Zeronda Tyler 4
Accession 0001415889-25-000156
CIK 0001566044other
Filed
Jan 1, 7:00 PM ET
Accepted
Jan 2, 5:45 PM ET
Size
5.1 KB
Accession
0001415889-25-000156
Insider Transaction Report
Form 4
Zeronda Tyler
CHIEF FINANCIAL OFFICER
Transactions
- Tax Payment
Common Stock
2024-12-31$3.35/sh−4,675$15,661→ 126,892 total
Footnotes (1)
- [F1]Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.
Documents
Issuer
VYNE Therapeutics Inc.
CIK 0001566044
Entity typeother
Related Parties
1- filerCIK 0001867033
Filing Metadata
- Form type
- 4
- Filed
- Jan 1, 7:00 PM ET
- Accepted
- Jan 2, 5:45 PM ET
- Size
- 5.1 KB